|
Showing 1 - 3 of
3 matches in All Departments
Tuberculosis remains primary cause of comparatively high mortality
worldwide. The statistics highlighted that three million people
worldwide die annually from complication of TB and there are
estimated 8 million of new cases each year, and today more people
die from tuberculosis than ever before. In recent history, however,
poor compliance with the prolonged and complicated chemotherapeutic
regimens currently used to treat the disease, in conjunction with
the advent of the AIDS epidemic and the increased mobility of human
populations, has led to the emergence of numerous multidrug
resistant Mycobacterium tuberculosis strain. The aim of this review
is to showcase treatment of tuberculosis in HIV patients.
This review has been aimed at the treatment of rheumatoid arthritis
and their significance. Rheumatoid arthritis is the most important
systemic disease. The current review information has been found to
reveal both remarkable active medicine and a variety of valuable
practical applications. An interest in the exploration of this
medicine has undoubtedly been growing due to their proven utility
as attractive lead structures for the design of novel agents with a
mechanism of action that sometimes differs from that of clinically
authorized current antirheumatic drugs. Therefore, in the present
review work we have focussed our attention on the information
revealing rheumatoid arthritis treatment.
A series of
Ethyl-3-methyl-5-(substituted-phenyl)-6,7,8,9-tetrahydro-5H-thiazolo
2,3-b]quinazoline-2-carboxylate derivatives have been synthesize
from cyclohexanone and substituted benzaldehyde with the aim of
developing potential antimicrobials and antitubercular agents. It
was characterized by FT-IR, 1H NMR and Mass spectroscopy. All the
newly synthesized compounds were screened for their antimicrobial
and antifungal activities on Staphylococcus aureus, Staphylococcus
epidermidis, Micrococcus luteus, Bacillus cereus (Gram-positive
bacteria), Escherichia coli, Pseudomonas aeruginosa, Klebsiella
pneumonia (Gram-negative bacteria), Aspergillus fumigates, Candida
albicans (Fungi). All the synthesized compounds were also evaluated
for their antitubercular activity against Mycobacterium
tuberculosis strain H37Ra.
|
You may like...
Icebreaker
Hannah Grace
Paperback
R280
R189
Discovery Miles 1 890
Honey & Spice
Bolu Babalola
Paperback
(1)
R469
Discovery Miles 4 690
It Ends With Us
Colleen Hoover
Paperback
(5)
R296
R212
Discovery Miles 2 120
Not in Love
Ali Hazelwood
Paperback
R280
R189
Discovery Miles 1 890
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.